Table 1. Demographic and clinical data of glaucoma and cataract patients.
| Characteristics | Glaucoma patients | Cataract non-glaucomatous patients | p-value |
|---|---|---|---|
| Total number | 37 | 23 | |
| Glaucoma subgroups | 25 POAG | ||
| 12 PACG | |||
| Age (Mean±SDa) | 69.9±7.6 | 66.5±11.8 | 0.228d |
| Gender | 0.926e | ||
| Male | 17 | 11 | |
| Female | 20 | 12 | |
| Race | 0.600e | ||
| Chinese | 33 | 19 | |
| Malay | 3 | 2 | |
| Indian | 1 | 1 | |
| Others | 0 | 1 | |
| AXLb (Mean±SD) | POAG: 24.2±1.8 | 23.8±1.6 | 0.026df |
| PACG: 23.0±0.9 | 0.250dg | ||
| 0.023dh | |||
| Surgery types | Number of eyes | Number of eyes | |
| Phacotrabeculectomy | 19 | 0 | |
| Trabeculectomy | 4 | 0 | |
| Phacoemulsification | 15 | 23 | |
| Medical Therapyc | Number of eyes | Number of eyes | |
| BB | 34 | 0 | |
| PGA | 28 | 0 | |
| AA | 12 | 0 | |
| CAI | 8 | 0 | |
| Number of drops | |||
| One | 6 | 0 | |
| Two or more | 32 | 0 | |
aSD: Standard deviation; cAXL: axial length; cBB: beta-blocker, AA: alpha-agonist, CAI: carbonic anhydrase inhibitor, PGA: prostaglandin analog; d2-samples independent t-test; ePearson's χ2; fbetween POAG and PACG; gbetween POAG and cataract; hbetween PACG and cataract.